ArticleBMC medical imaging2026
Reduced right/left ventricular blood pool T2 ratio on cardiac magnetic resonance indicates cognitive impairment in heart failure secondary to ischemic heart disease.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeThe right-to-left ventricular blood pool T2 ratio (RV/LV T2 ratio) derived from cardiac magnetic resonance (CMR) T2 mapping is a potential biomarker of blood oxygenation. This study investigated the association between RV/LV T2 ratio and cognitive performance in heart failure (HF) secondary to ischemic heart disease (IHD).
methodsThis retrospective study included 52 patients with chronic HF and 26 healthy controls, all of whom underwent CMR and neuropsychological testing. Regions of interest were manually drawn in RV and LV blood pools to calculate RV/LV T2 ratio. Cognitive performance was assessed by the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA). Group comparisons and linear, multivariate, and mediation analyses were performed.
resultsHC demonstrated higher RV/LV T2 ratio than patients with HF with preserved or reduced and mildly reduced ejection fraction (p = 0.012, and p < 0.001). Patients with cognitive impairment (MoCA-defined) showed lower RV/LV T2 ratios than cognitively normal patients (p = 0.010). RV/LV T2 ratio was positively related to MMSE (β = 0.336, p = 0.020) and MoCA score (β = 0.563, p < 0.001). In multivariate linear regression analysis, RV/LV T2 ratio was the only CMR predictor for MoCA score (β = 0.340, p = 0.015). Mediation analysis showed RV/LV T2 ratio partially mediated the correlation between stroke volume and MoCA score, with a mediation effect ratio of 44.3%.
conclusionRV/LV T2 ratio is an additional CMR biomarker to evaluate the cognitive performance in patients with HF secondary to IHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.